Catherine M Hardie, THERAPY DIR II | |
3580 Atlanta Ave, Hapeville, GA 30354-1706 | |
(615) 778-4066 | |
Not Available |
Full Name | Catherine M Hardie |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 3580 Atlanta Ave, Hapeville, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982720157 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | 6855 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Catherine M Hardie, THERAPY DIR II 720 Cool Springs Blvd, Suite 300, Franklin, TN 37067-2626 Ph: (615) 778-4066 | Catherine M Hardie, THERAPY DIR II 3580 Atlanta Ave, Hapeville, GA 30354-1706 Ph: (615) 778-4066 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the Board of Appeals of the European Patent Office (EPO) has ruled that claims of the Kreutzer-Limmer '945 (EP 1214945) patent meet needed requirements under European patent law. The '945 patent comprises broad claims covering the length and certain structural requirements for siRNAs that are important for advancement of RNAi therapeutics.
Researchers at Queen's University Belfast are taking the first step towards discovering the true effectiveness of brain training exercises with the release of their own app aimed at those over 50.
On March 28, the Food and Drug Administration (FDA) exercised its Emergency Use Authorization (EUA) authority to allow the use of hydroxychloroquine for the treatment of COVID-19. On June 15, after a number of studies failed to find positive effects, the agency revoked this authorization.
Researchers in the Hereditary Endocrine Cancer Group of the Spanish National Cancer Research Centre - led by Alberto Cascón and Mercedes Robledo - have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component: pheochromocytomas and paragangliomas that affect the suprarenal and parathyroid glands (groups of chromaffin cells in the central nervous system), respectively.
One year ago WHO created the COVID-19 Solidarity Response Fund to respond to the unprecedented show of support by individuals and companies to help WHO in the fight against COVID-19.
› Verified 4 days ago
Stephen A Dawkins, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 535 N Central Ave, Hapeville, GA 30354 Phone: 404-761-4040 Fax: 404-761-4008 | |
Dr. Brandon Dawkins, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 535 N Central Ave, Hapeville, GA 30354 Phone: 404-761-4040 | |
Jeffrey Wainstein, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3580 Atlanta Ave, Hapeville, GA 30354 Phone: 404-768-3351 | |
Arlene Renee Emmons, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 535 N Central Ave, Hapeville, GA 30354 Phone: 404-763-4040 Fax: 404-763-4008 | |
Peter Deziel, ASST. V.P. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 3580 Atlanta Ave, Hapeville, GA 30354 Phone: 615-778-4066 | |
Nicola B Lee, M.D. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 3580 Atlanta Ave, Hapeville, GA 30354 Phone: 615-778-4066 |